NLS Pharmaceutics Ltd. (NASDAQ:NLSP – Get Free Report) dropped 0.6% on Tuesday . The stock traded as low as $1.58 and last traded at $1.63. Approximately 13,242 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 846,842 shares. The stock had previously closed at $1.64.
NLS Pharmaceutics Stock Down 0.6%
The firm has a 50 day moving average of $1.52 and a two-hundred day moving average of $2.15.
About NLS Pharmaceutics
NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).
See Also
- Five stocks we like better than NLS Pharmaceutics
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- NVIDIA Stock Surges on Bullish News: How High Could It Climb?
- How to invest in marijuana stocks in 7 steps
- Why Boeing May Be Ready to Take Off After Latest Developments
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- eBay Nears Big Breakout: Time to Buy the Under-the-Radar Winner?
Receive News & Ratings for NLS Pharmaceutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NLS Pharmaceutics and related companies with MarketBeat.com's FREE daily email newsletter.
